Crescent Capital BDC Inc (CCAP)
Official siteFINANCIAL SERVICES • ASSET MANAGEMENT • NASDAQ
Market Cap: $371.41M
Last updated: Nov 17, 2026 at 4:15 PM ET
Crescent Capital BDC Inc (CCAP) Statistics
Crescent Capital BDC (CCAP) has a market cap of $371.41M and an enterprise value of $1.24B. Its net debt of $873.07M equals 235.07% of its market cap. Revenue grew 21.00% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 235.07% above the market cap, as debt exceeds cash.
| Market Cap | $371.41M |
|---|---|
| Enterprise Value | $1.24B |
| Latest price (Nov 17, 2026) | $9.88 |
Key Dates
The next earnings report is expected on Feb 23, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Dec 31, 2026.
| Next Earnings Date | Feb 23, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 9, 2026 |
| Next Ex-Dividend Date | Dec 31, 2026 |
| Next Payment Date | Jan 15, 2027 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 2.9x and 0.6x. Its year-end P/E ranged from 6.6x to 10.5x from 2020 to 2025.
| P/E Ratio | 6.2x |
|---|---|
| Forward P/E | 6.5x |
| P/S Ratio | 2.9x |
| Forward P/S | 2.5x |
| P/B Ratio | 0.6x |
| P/FCF Ratio | 7.0x |
| P/OCF Ratio | 7.1x |
Enterprise Valuation
Counting debt and cash, the company is valued at 20.5x EBITDA and 23.8x free cash flow.
| EV / Sales | 10.0x |
|---|---|
| EV / EBITDA | 20.5x |
| EV / FCF | 23.8x |
Price Statistics
The stock is down 20.33% over 52 weeks and trades 6.24% above its 50-day average.
| Beta (1Y) | 0.55 |
|---|---|
| 52-Week Change | -20.33% |
| 1-Month Change | +13.56% |
| 3-Month Change | -4.65% |
| 6-Month Change | -5.24% |
| 5-Year Change | -53.86% |
| Total Return (1Y) | -7.34% |
| Total Return (3Y CAGR) | -5.85% |
| Total Return (5Y CAGR) | -1.61% |
| Return vs SPY (1Y) | -29.91% |
| Max Drawdown (1Y) | -38.78% |
| Max Drawdown (3Y) | -48.69% |
| Sharpe Ratio (1Y) | -0.69 |
| Correlation with SPY (1Y) | 0.25 |
| 50-Day Average | $9.30 |
| 200-Day Average | $10.92 |
| 52-Week Range | $8.39 to $13.42 |
| RSI (14 Days) | 57.7 |
| Average Volume (20 Days) | 200.25K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.54x current liabilities, and total debt is 1.39x shareholder equity.
| Current Ratio | 1.54x |
|---|---|
| Quick Ratio | 1.54x |
| Debt / Equity | 1.39x |
| Debt / EBITDA | 15.03x |
| Debt / FCF | 17.48x |
| Interest Coverage | 0.77x |
Returns and Efficiency
Return on invested capital is 1.84% over the last 12 months, against a 5-year average of 12.50%.
| Return on Equity (ROE) | -0.02% |
|---|---|
| Return on Assets (ROA) | -0.01% |
| Return on Invested Capital (ROIC) | 1.84% |
| ROE (5Y Average) | 8.30% |
| ROA (5Y Average) | 3.85% |
| ROIC (5Y Average) | 12.50% |
| Asset Turnover | 0.08x |
| Receivables Turnover | 15.63x |
Scores
CCAP has an Altman Z-Score of 0.15, in the distress zone below 1.81, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 0.15 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 7 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $124.18M over the last 12 months.
| Revenue | $124.18M |
|---|---|
| Revenue Growth (YoY) | +21.00% |
| Gross Profit | $96.54M |
| Operating Income | $83.40M |
| Pretax Income | $1.84M |
| Net Income | -$156.00K |
| Reported EPS (TTM) | $1.60 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 40.81% of the $1.60B in total assets.
| Cash and Equivalents | $36.20M |
|---|---|
| Total Debt | $909.27M |
| Net Debt | $873.07M |
| Net Debt Per Share | $23.70 |
| Working Capital | $15.33M |
| Shareholder Equity | $652.93M |
| Book Value Per Share | $17.72 |
| Total Assets | $1.60B |
| Total Liabilities | $948.51M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $0 of capital spending, operating cash flow left $52.01M of free cash flow.
| Operating Cash Flow | $52.01M |
|---|---|
| Capital Expenditures | $0 |
| Free Cash Flow | $52.01M |
| FCF Per Share | $1.41 |
| Depreciation and Amortization | $30.24M |
| Dividends Paid | $76.88M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 67.16%, against a 5-year average of 64.94%.
| Gross Margin | 77.75% |
|---|---|
| Operating Margin | 67.16% |
| Pretax Margin | 1.48% |
| Net Margin | -0.13% |
| FCF Margin | 41.88% |
| Gross Margin (5Y Average) | 68.77% |
| Operating Margin (5Y Average) | 64.94% |
| Net Margin (5Y Average) | 52.67% |
Growth
Revenue grew 44.19% a year over 3 years, and EPS fell 2.84% a year.
| Revenue Growth (3Y CAGR) | +44.19% |
|---|---|
| Revenue Growth (5Y CAGR) | +27.40% |
| EPS Growth (3Y CAGR) | -2.84% |
| EPS Growth (5Y CAGR) | -0.34% |
| FCF Growth (3Y CAGR) | +38.79% |
| Operating Income Growth (3Y CAGR) | +93.15% |
| Book Value Per Share Growth (2Y CAGR) | -2.32% |
| Tangible Book Per Share Growth (2Y CAGR) | -2.31% |
Dividends and Yields
CCAP pays out 75.81% of earnings as dividends.
| Dividend Per Share (Annual) | $1.48 |
|---|---|
| Payout Ratio | 75.81% |
| FCF Payout Ratio | 147.84% |
| Earnings Yield | 16.13% |
| FCF Yield | 14.29% |
| Shareholder Yield | 21.12% |
Peer Position
Against 12 similar companies, CCAP has the 11th highest P/E.
P/E RatioPeer median 7.8x
P/S RatioPeer median 4.2x
ROICPeer median 2.91%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -12.28%
| P/E Ratio | 6.2x vs 7.8x median |
|---|---|
| P/S Ratio | 2.9x vs 4.2x median |
| ROIC | 1.84% vs 2.91% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +21.00% vs -12.28% median |
Analyst Forecast
Consensus estimates put revenue growth at -5.15% and EPS growth at -9.40% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | -5.15% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | -9.40% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About CCAP
What is CCAP's market cap?
Crescent Capital BDC has a market cap of $371.41M. Its enterprise value, which adds debt and subtracts cash, is $1.24B.
What is CCAP's P/E ratio?
Crescent Capital BDC has a trailing P/E ratio of 6.2x and a forward P/E of 6.5x.
How many shares of CCAP are outstanding?
Crescent Capital BDC has 36.85M shares outstanding. The count is down 0.58% from a year earlier.
Does CCAP pay a dividend?
No. Crescent Capital BDC does not pay a dividend.
How much debt does CCAP have?
Crescent Capital BDC has $909.27M of total debt and $36.20M of cash and equivalents, a net debt position of $873.07M.
CCAP pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors